KNC Laboratories Co.,Ltd.(JP:6568)
Â¥1,176.00+6.00 (+0.51%)
JP:6568
KNC Laboratories Co.,Ltd. financials statements
Â¥1,176.00
At close:+6.00 (+0.51%)
Want to see JP:6568 full AI Analyst Report?
KNC Laboratories Co.,Ltd. (6568) Ratios
0 Followers
KNC Laboratories Co.,Ltd. Ratios
JP:6568's free cash flow for Q? was ―. For the fiscal year, JP:6568's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.87 | 3.30 | 2.88 | 2.73 | 3.10 |
| Quick Ratio | 1.66 | 2.17 | 2.03 | 1.90 | 2.24 |
| Cash Ratio | 0.80 | 1.05 | 1.12 | 0.84 | 0.96 |
| Solvency Ratio | 0.26 | 0.24 | 0.44 | 0.67 | 0.47 |
| Operating Cash Flow Ratio | 0.83 | 0.66 | 1.08 | 0.73 | 0.29 |
| Short-Term Operating Cash Flow Coverage | 2.05 | 1.74 | 4.87 | 2.12 | 0.91 |
| Net Current Asset Value | ¥ 247.77M | ¥ 795.53M | ¥ 3.02B | ¥ 3.80B | ¥ 2.97B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.15 | 0.11 | 0.10 | 0.12 |
| Debt-to-Equity Ratio | 0.26 | 0.23 | 0.15 | 0.13 | 0.16 |
| Debt-to-Capital Ratio | 0.20 | 0.19 | 0.13 | 0.12 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.15 | 0.14 | 0.09 | 0.05 | 0.09 |
| Financial Leverage Ratio | 1.54 | 1.49 | 1.42 | 1.31 | 1.32 |
| Debt Service Coverage Ratio | 1.79 | 1.88 | 3.63 | 2.60 | 2.44 |
| Interest Coverage Ratio | 29.74 | 40.21 | 222.18 | 223.32 | 109.63 |
| Debt to Market Cap | 0.38 | 0.37 | 0.18 | 0.13 | 0.20 |
| Interest Debt Per Share | 469.26 | 406.12 | 256.54 | 200.52 | 216.99 |
| Net Debt to EBITDA | 0.62 | 0.40 | -0.44 | -0.25 | -0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.26% | 27.77% | 36.00% | 38.29% | 28.32% |
| EBIT Margin | 11.66% | 11.58% | 22.97% | 25.29% | 12.46% |
| EBITDA Margin | 25.22% | 22.33% | 33.04% | 35.94% | 24.94% |
| Operating Profit Margin | 11.27% | 9.44% | 22.74% | 25.08% | 14.71% |
| Pretax Profit Margin | 11.28% | 11.35% | 22.86% | 25.18% | 12.32% |
| Net Profit Margin | 8.43% | 9.01% | 16.31% | 17.88% | 8.65% |
| Continuous Operations Profit Margin | 8.43% | 9.01% | 16.31% | 17.88% | 8.65% |
| Net Income Per EBT | 74.69% | 79.45% | 71.33% | 71.02% | 70.19% |
| EBT Per EBIT | 100.12% | 120.23% | 100.57% | 100.40% | 83.76% |
| Return on Assets (ROA) | 3.54% | 3.65% | 8.02% | 10.02% | 4.61% |
| Return on Equity (ROE) | 5.44% | 5.45% | 11.41% | 13.14% | 6.08% |
| Return on Capital Employed (ROCE) | 5.42% | 4.30% | 13.30% | 17.07% | 9.19% |
| Return on Invested Capital (ROIC) | 3.82% | 3.26% | 9.10% | 11.29% | 6.12% |
| Return on Tangible Assets | 3.55% | 3.66% | 8.04% | 10.06% | 4.63% |
| Earnings Yield | 8.06% | 8.80% | 13.53% | 12.69% | 7.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.24 | 3.40 | 3.49 | 3.09 | 2.95 |
| Payables Turnover | 15.61 | 17.06 | 19.52 | 17.42 | 19.20 |
| Inventory Turnover | 2.04 | 2.32 | 2.33 | 2.34 | 3.01 |
| Fixed Asset Turnover | 0.74 | 0.73 | 1.08 | 1.20 | 1.08 |
| Asset Turnover | 0.42 | 0.40 | 0.49 | 0.56 | 0.53 |
| Working Capital Turnover Ratio | 1.77 | 1.52 | 1.77 | 1.91 | 1.83 |
| Cash Conversion Cycle | 225.36 | 243.10 | 242.89 | 253.41 | 225.81 |
| Days of Sales Outstanding | 69.63 | 107.44 | 104.70 | 118.06 | 123.54 |
| Days of Inventory Outstanding | 179.12 | 157.05 | 156.89 | 156.30 | 121.27 |
| Days of Payables Outstanding | 23.39 | 21.40 | 18.70 | 20.95 | 19.01 |
| Operating Cycle | 248.75 | 264.50 | 261.59 | 274.36 | 244.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 292.41 | 192.45 | 415.32 | 258.55 | 75.27 |
| Free Cash Flow Per Share | -46.98 | -235.15 | 110.18 | 112.00 | -31.94 |
| Dividend Paid and CapEx Coverage Ratio | 0.79 | 0.42 | 1.23 | 1.42 | 0.57 |
| Capital Expenditure Coverage Ratio | 0.86 | 0.45 | 1.36 | 1.76 | 0.70 |
| Operating Cash Flow Coverage Ratio | 0.63 | 0.48 | 1.63 | 1.30 | 0.35 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.18 | 0.35 | 0.23 | 0.08 |
| Free Cash Flow Yield | -3.83% | -21.69% | 7.71% | 7.11% | -2.95% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.40 | 11.36 | 7.39 | 7.88 | 13.08 |
| Price-to-Sales (P/S) Ratio | 1.04 | 1.02 | 1.21 | 1.41 | 1.13 |
| Price-to-Book (P/B) Ratio | 0.67 | 0.62 | 0.84 | 1.03 | 0.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -26.14 | -4.61 | 12.98 | 14.07 | -33.91 |
| Price-to-Operating Cash Flow Ratio | 4.20 | 5.63 | 3.44 | 6.10 | 14.39 |
| Price-to-Earnings Growth (PEG) Ratio | 3.29 | -0.22 | -2.25 | 0.06 | 0.22 |
| Enterprise Value Multiple | 4.76 | 4.99 | 3.20 | 3.67 | 4.38 |
| Enterprise Value | 10.93B | 9.11B | 9.69B | 11.39B | 8.12B |
| EV to EBITDA | 4.76 | 4.99 | 3.20 | 3.67 | 4.38 |
| EV to Sales | 1.20 | 1.11 | 1.06 | 1.32 | 1.09 |
| EV to Free Cash Flow | -30.05 | -5.01 | 11.40 | 13.19 | -32.71 |
| EV to Operating Cash Flow | 4.83 | 6.13 | 3.02 | 5.71 | 13.88 |
| Tangible Book Value Per Share | 1811.81 | 1743.01 | 1689.17 | 1514.75 | 1354.60 |
| Shareholders’ Equity Per Share | 1819.68 | 1749.68 | 1696.09 | 1522.98 | 1360.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.21 | 0.29 | 0.29 | 0.30 |
| Revenue Per Share | 1175.21 | 1058.45 | 1186.46 | 1118.79 | 957.23 |
| Net Income Per Share | 99.02 | 95.42 | 193.50 | 200.06 | 82.78 |
| Tax Burden | 0.75 | 0.79 | 0.71 | 0.71 | 0.70 |
| Interest Burden | 0.97 | 0.98 | 1.00 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.05 | 0.01 | 0.02 | 0.02 |
| SG&A to Revenue | 0.15 | 0.13 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.95 | 2.02 | 2.15 | 1.29 | 0.64 |
Currency in JPY
